HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.

AbstractPURPOSE:
To determine whether the presence of a hypovascular nodule in the liver showing hypointensity on hepatocyte-phase of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) is a risk factor for hypervascular hepatocellular carcinoma (HCC) in patients with chronic liver disease.
MATERIALS AND METHODS:
Forty-one patients with pathologically confirmed hypervascular HCC and 41 age- and gender-matched controls were retrospectively selected. These patients had undergone EOB-MRI at least twice: the latest EOB-MRI and EOB-MRI performed more than 6 months earlier. History of hypervascular HCC, presence of a hypointense hypovascular nodule in previous hepatocyte-phase MR images, percent prothrombin time, platelet count, serum levels of albumin, total bilirubin, aspartate aminotransferase, alanine aminotransferase, α-fetoprotein, and protein induced by vitamin K absence-II (PIVKA-II) were variables evaluated by multivariate logistic regression analysis.
RESULTS:
Multivariate analysis revealed that serum albumin level (odds ratio [95% confidence interval], 0.19 [0.06-0.57]; P = 0.0024), history of hypervascular HCC (8.62 [2.71-32.8]; P = 0.0001), and presence of a hypointense hypovascular nodule (4.18 [1.18-17.2]; P = 0.0256) were significant risk factors for hypervascular HCC.
CONCLUSION:
Patients with chronic liver disease showing a hypointense hypovascular nodule in the liver on hepatocyte-phase EOB-MRI have a high risk of HCC development.
AuthorsShintaro Ichikawa, Tomoaki Ichikawa, Utaroh Motosugi, Katsuhiro Sano, Hiroyuki Morisaka, Nobuyuki Enomoto, Masanori Matsuda, Hideki Fujii, Tsutomu Araki
JournalJournal of magnetic resonance imaging : JMRI (J Magn Reson Imaging) Vol. 39 Issue 2 Pg. 293-7 (Feb 2014) ISSN: 1522-2586 [Electronic] United States
PMID23633285 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Wiley Periodicals, Inc.
Chemical References
  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA
Topics
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (blood supply, pathology)
  • Case-Control Studies
  • Contrast Media
  • Female
  • Gadolinium DTPA
  • Hepatocytes (pathology)
  • Humans
  • Liver Cirrhosis (pathology)
  • Liver Neoplasms (blood supply, pathology)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Middle Aged
  • Neovascularization, Pathologic (pathology)
  • Prognosis
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: